T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
39 hedge funds and large institutions have $7.39M invested in T2 Biosystems, Inc in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 10 closing their positions.
220% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 5
9% less funds holding
Funds holding: 43 → 39 (-4)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
37% less call options, than puts
Call options by funds: $33K | Put options by funds: $52K
42% less capital invested
Capital invested by funds: $12.8M → $7.39M (-$5.38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$594K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$316K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$312K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$166K |
| 5 |
GS
Gagnon Securities
New York
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.05M |
| 2 |
D.E. Shaw & Co
New York
|
-$266K |
| 3 |
Millennium Management
New York
|
-$202K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$66K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$49.9K |
TTOO Hedge Fund Activity: Q1 2020 in Review
39 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q1 2020, worth a combined $7.39M — down 42% from $12.8M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TTOO and 9 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 16 added.
The largest buyer was Vanguard Group, adding an estimated $594K. The largest seller was Morgan Stanley, cutting an estimated $1.05M.
- 39 institutional investors held T2 Biosystems, Inc (TTOO) as of Q1 2020, down from 43 in Q4 2019.
- Funds reported $7.39M of T2 Biosystems, Inc stock for Q1 2020, down 42% quarter-over-quarter.
- 9 funds opened new T2 Biosystems, Inc positions in Q1 2020 and 10 closed out, a net change of -1 holder.
- The largest T2 Biosystems, Inc buyer in Q1 2020 was Vanguard Group, an estimated $594K added.
- The largest T2 Biosystems, Inc seller in Q1 2020 was Morgan Stanley, an estimated $1.05M sold.
Based on aggregated 13F filings for Q1 2020.